Matches in Wikidata for { <http://www.wikidata.org/entity/Q40033522> ?p ?o ?g. }
- Q40033522 description "2007 nî lūn-bûn" @default.
- Q40033522 description "2007年の論文" @default.
- Q40033522 description "2007年論文" @default.
- Q40033522 description "2007年論文" @default.
- Q40033522 description "2007年論文" @default.
- Q40033522 description "2007年論文" @default.
- Q40033522 description "2007年論文" @default.
- Q40033522 description "2007年论文" @default.
- Q40033522 description "2007年论文" @default.
- Q40033522 description "2007年论文" @default.
- Q40033522 description "2007年论文" @default.
- Q40033522 description "2007年论文" @default.
- Q40033522 description "2007年论文" @default.
- Q40033522 description "2007년 논문" @default.
- Q40033522 description "article científic" @default.
- Q40033522 description "article scientific" @default.
- Q40033522 description "article scientifique" @default.
- Q40033522 description "articol științific" @default.
- Q40033522 description "articolo scientifico" @default.
- Q40033522 description "artigo científico" @default.
- Q40033522 description "artigo científico" @default.
- Q40033522 description "artigo científico" @default.
- Q40033522 description "artikel ilmiah" @default.
- Q40033522 description "artikull shkencor" @default.
- Q40033522 description "artikulong pang-agham" @default.
- Q40033522 description "artykuł naukowy" @default.
- Q40033522 description "artículo científico publicado en 2007" @default.
- Q40033522 description "artículu científicu espublizáu en 2007" @default.
- Q40033522 description "bilimsel makale" @default.
- Q40033522 description "bài báo khoa học" @default.
- Q40033522 description "naučni članak" @default.
- Q40033522 description "scienca artikolo" @default.
- Q40033522 description "scientific article published on December 2007" @default.
- Q40033522 description "scientific article published on December 2007" @default.
- Q40033522 description "scientific article published on December 2007" @default.
- Q40033522 description "teaduslik artikkel" @default.
- Q40033522 description "tieteellinen artikkeli" @default.
- Q40033522 description "tudományos cikk" @default.
- Q40033522 description "vedecký článok" @default.
- Q40033522 description "vetenskaplig artikel" @default.
- Q40033522 description "videnskabelig artikel" @default.
- Q40033522 description "vitenskapelig artikkel" @default.
- Q40033522 description "vitskapeleg artikkel" @default.
- Q40033522 description "vědecký článek" @default.
- Q40033522 description "wetenschappelijk artikel" @default.
- Q40033522 description "wissenschaftlicher Artikel" @default.
- Q40033522 description "επιστημονικό άρθρο" @default.
- Q40033522 description "мақолаи илмӣ" @default.
- Q40033522 description "наукова стаття, опублікована в грудні 2007" @default.
- Q40033522 description "научна статия" @default.
- Q40033522 description "научная статья" @default.
- Q40033522 description "научни чланак" @default.
- Q40033522 description "научни чланак" @default.
- Q40033522 description "מאמר מדעי" @default.
- Q40033522 description "مقالة علمية نشرت في ديسمبر 2007" @default.
- Q40033522 description "ডিসেম্বর ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q40033522 description "บทความทางวิทยาศาสตร์" @default.
- Q40033522 description "სამეცნიერო სტატია" @default.
- Q40033522 name "PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib" @default.
- Q40033522 name "PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib" @default.
- Q40033522 type Item @default.
- Q40033522 label "PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib" @default.
- Q40033522 label "PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib" @default.
- Q40033522 prefLabel "PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib" @default.
- Q40033522 prefLabel "PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib" @default.
- Q40033522 P1433 Q40033522-57B77671-E756-4F14-B5FF-A8A91B4F8999 @default.
- Q40033522 P1476 Q40033522-FEFFA31D-CCD5-4C61-9D6A-F2A9875876B7 @default.
- Q40033522 P2093 Q40033522-09E43D90-57A6-41D6-8859-F3375F9188D2 @default.
- Q40033522 P2093 Q40033522-1DEF23ED-6CFA-41B5-BE16-F7F21B12D858 @default.
- Q40033522 P2093 Q40033522-238FB442-DA6C-494A-97EC-61AD48B8EEF4 @default.
- Q40033522 P2093 Q40033522-28540772-C4AB-4DE4-9264-62EF6D5CC804 @default.
- Q40033522 P2093 Q40033522-57950024-DF5E-4E4C-99B7-E6DAF65656E5 @default.
- Q40033522 P2093 Q40033522-71C25228-C71F-42EB-9D61-84706F7B22C3 @default.
- Q40033522 P2093 Q40033522-76AF60EA-6A9C-4C1C-B6E6-63021E8A5CF7 @default.
- Q40033522 P2093 Q40033522-7A65AECE-EA54-4F80-A2AC-78E425B09884 @default.
- Q40033522 P2093 Q40033522-7E871D4C-E143-4A69-A3B8-1752E9B25A78 @default.
- Q40033522 P2093 Q40033522-7EA24A4C-6350-456E-AD2F-D05FC7A6348D @default.
- Q40033522 P2093 Q40033522-93E3873C-6718-4EDD-A64A-D7D1226B221D @default.
- Q40033522 P2093 Q40033522-94012117-0ADA-48D4-9485-0A64C3485003 @default.
- Q40033522 P2093 Q40033522-A33B4556-D2C7-476F-96AA-CD3A9431B555 @default.
- Q40033522 P2093 Q40033522-B98686CF-66DE-443C-A2FA-C77863D0F0E5 @default.
- Q40033522 P304 Q40033522-C117133A-A197-46CC-8D4D-8B0BD35322E7 @default.
- Q40033522 P31 Q40033522-515B56A4-6A5C-4EE2-9F62-8398D2E979A8 @default.
- Q40033522 P356 Q40033522-D6FED6B8-73D7-4BCB-A969-4F6D6DA752A3 @default.
- Q40033522 P407 Q40033522-23C9B77B-6C77-421C-834D-B7B2D127F58E @default.
- Q40033522 P433 Q40033522-C73E920C-5835-4194-AF7B-27B0945008B7 @default.
- Q40033522 P478 Q40033522-EB94A468-DD4E-45F8-95CE-C8EC82FDEF1F @default.
- Q40033522 P50 Q40033522-251107D4-683F-4D12-86CF-45C121A7722B @default.
- Q40033522 P50 Q40033522-5D5D1538-2FC9-40ED-9F25-EBDA59DCE7E1 @default.
- Q40033522 P50 Q40033522-7C05D959-15A9-4237-A6BA-95CED87111F8 @default.
- Q40033522 P50 Q40033522-AFFFC2BF-E7E2-47EE-8A89-6926A0007EAA @default.
- Q40033522 P577 Q40033522-9C494CB2-269D-406F-96A0-B7D498AA20C7 @default.
- Q40033522 P5875 Q40033522-D77BE258-E7AB-4D7D-BD8A-9CCFF0C276E1 @default.
- Q40033522 P698 Q40033522-1139B704-0596-4896-AB73-EFAF0A045997 @default.
- Q40033522 P921 Q40033522-3C238017-11B4-41A2-AF4D-D212D6E7B9C8 @default.
- Q40033522 P921 Q40033522-4FE680DB-9BFB-47BA-A3B3-C086EC04974F @default.
- Q40033522 P356 0008-5472.CAN-07-1885 @default.
- Q40033522 P698 18089823 @default.
- Q40033522 P1433 Q326097 @default.
- Q40033522 P1476 "PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib" @default.